Centerra Gold (CG) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
30 Apr, 2026Executive summary
Achieved strong operational and financial performance in Q1 2026, with production in line with plan and robust free cash flow generation at both Mount Milligan and Öksüt.
Cash balance increased to $543 million, supporting ongoing investments and $33 million returned to shareholders via buybacks and dividends.
Advanced key growth projects: Kemess PEA released, Mount Milligan PFS delivered, Thompson Creek on track for mid-2027 production, and Goldfield progressing toward late 2028 start.
Sustainability initiatives advanced, including water rights at Goldfield and community engagement at Öksüt.
Financial highlights
Revenue rose 62% year-over-year to $484.7 million; net earnings up 160% to $79.4 million; adjusted net earnings up 234% to $88.2 million.
Adjusted net earnings of $88 million ($0.44 per share) in Q1 2026; EPS was $0.40.
Cash from operations: $120 million; free cash flow: $49 million; total liquidity at quarter-end: $943 million.
Shareholder returns in Q1 2026 were $33 million ($22.5 million buybacks, $10.1 million dividends).
Gold production costs: $1,649/oz; AISC on by-product basis: $1,705/oz; average realized gold price: $4,172/oz; copper price: $4.48/lb.
Outlook and guidance
2026 gold production guidance: 250,000–280,000 oz; copper: 50–60 million lbs.
Mount Milligan and Öksüt expected to meet full-year production and cost guidance; Goldfield and Thompson Creek on track for first production in late 2028 and mid-2027, respectively.
Mount Milligan 2026 guidance: 140,000–155,000 oz gold, 50–60M lbs copper; gold production costs $1,450–$1,550/oz, AISC $1,200–$1,300/oz.
Öksüt 2026 guidance: 110,000–125,000 oz gold; gold production costs $1,650–$1,750/oz, AISC $1,850–$1,950/oz.
Diesel price volatility not expected to materially impact 2026 cost or CapEx guidance due to hedging.
Latest events from Centerra Gold
- All director nominees, auditor appointment, and executive compensation approach were approved.CG
AGM 20265 May 2026 - 2025 exceeded production and financial targets, advancing growth and delivering record returns.CG
Q4 202520 Feb 2026 - Strong balance sheet and discounted valuation support organic growth in gold, copper, and molybdenum.CG
Investor presentation20 Feb 2026 - Q2 2024 saw strong results, robust liquidity, and ongoing capital returns with steady guidance.CG
Q2 20242 Feb 2026 - Restart and ramp-up of US molybdenum assets target $472M NPV8% and 22% IRR by 2028.CG
Investor Update20 Jan 2026 - Strong Q3 cash flow, stable costs, and strategic project progress support 2024 targets.CG
Q3 202417 Jan 2026 - 2024 delivered robust cash flow; 2025 to focus on disciplined spending and project growth.CG
Q4 202421 Dec 2025 - All director nominees, auditor appointment, and executive compensation motions were approved.CG
AGM 202525 Nov 2025 - Q1 2025 saw strong cash flow, robust liquidity, and major project advances.CG
Q1 202524 Nov 2025